Lipedema não é obesidade: cirurgião explica diferenças e importância do diagnóstico precoce

Consumers may seek corrective diagnosis and specialized treatment, increasing healthcare spending on vascular surgery and dermatology services. Misdiagnosed patients previously pursuing obesity treatments may redirect spending toward lipedema-specific therapies, potentially increasing out-of-pocket costs due to limited insurance coverage for newly recognized condition.

Healthcare systems must develop diagnostic protocols and treatment guidelines for lipedema. Insurance coverage policies need revision to include lipedema treatments. Medical education requires updates on differential diagnosis. Potential for increased healthcare expenditure as 12% of population seeks proper diagnosis and treatment.